Ioannis Gkouzionis, Aisthesis Medical

Co-founder and CEO

Based in London, U.K., Aisthesis Medical, has developed a wearable medical device that alerts healthcare providers of a patient’s sepsis risk up to 48 hours before symptoms appear. Using AI and machine learning, the device monitors and analyzes various clinical data points, such as vital signs, medical history, medication and lab results, providing doctors and nurses with a sepsis risk score.